{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:00:33Z","timestamp":1766070033181,"version":"3.48.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.7759\/cureus.99543","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:56:27Z","timestamp":1766069787000},"source":"Crossref","is-referenced-by-count":0,"title":["Marked QTc Interval Prolongation Associated With Dronedarone in Paroxysmal Atrial Fibrillation and No Structural Disease"],"prefix":"10.7759","author":[{"given":"Sebastian","family":"Hernandez Mejia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joud","family":"Fahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayna","family":"Isber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidal","family":"Isber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh BN","year":"2007","unstructured":"Singh BN, Connolly SJ, Crijns HJ, et al.. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007, 357:987-99. 10.1056\/NEJMoa054686","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.100.22.2276","article-title":"Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone","volume":"100","author":"Sun W","year":"1999","unstructured":"Sun W, Sarma JS, Singh BN. Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. Circulation. 1999, 100:2276-81. 10.1161\/01.cir.100.22.2276","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.9.904","article-title":"Dronedarone: a new antiarrhythmic agent","volume":"30","author":"Oyetayo OO","year":"2010","unstructured":"Oyetayo OO, Rogers CE, Hofmann PO. Dronedarone: a new antiarrhythmic agent. Pharmacotherapy. 2010, 30:904-15. 10.1592\/phco.30.9.904","journal-title":"Pharmacotherapy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01118.x","article-title":"Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting","volume":"32","author":"Kao DP","year":"2012","unstructured":"Kao DP, Hiatt WR, Krantz MJ. Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. Pharmacotherapy. 2012, 32:767-71. 10.1002\/j.1875-9114.2012.01118.x","journal-title":"Pharmacotherapy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1330","article-title":"Ventricular ectopy and QTc-interval prolongation associated with dronedarone therapy","volume":"33","author":"Gonzalez JE","year":"2013","unstructured":"Gonzalez JE, Sauer WH, Krantz MJ. Ventricular ectopy and QTc-interval prolongation associated with dronedarone therapy. Pharmacotherapy. 2013, 33:e179-81. 10.1002\/phar.1330","journal-title":"Pharmacotherapy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051242","article-title":"Obstructive sleep apnea and atrial fibrillation","volume":"11","author":"Moula AI","year":"2022","unstructured":"Moula AI, Parrini I, Tetta C, et al.. Obstructive sleep apnea and atrial fibrillation. J Clin Med. 2022, 11:1242. 10.3390\/jcm11051242","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029443","article-title":"Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): a dose-response meta-analysis","volume":"101","author":"Zhang D","year":"2022","unstructured":"Zhang D, Ma Y, Xu J, Yi F. Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): a dose-response meta-analysis. Medicine (Baltimore). 2022, 101:e29443. 10.1097\/MD.0000000000029443","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly SJ","year":"2011","unstructured":"Connolly SJ, Camm AJ, Halperin JL, et al.. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011, 365:2268-76. 10.1056\/NEJMoa1109867","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser SH","year":"2009","unstructured":"Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009, 360:668-78. 10.1056\/NEJMoa0803778","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.045575","article-title":"Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19","volume":"40","author":"Zvyaga T","year":"2012","unstructured":"Zvyaga T, Chang SY, Chen C, et al.. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug Metab Dispos. 2012, 40:1698-711. 10.1124\/dmd.112.045575","journal-title":"Drug Metab Dispos"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards IR","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000, 356:1255-9. 10.1016\/S0140-6736(00)02799-9","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443120-marked-qtc-interval-prolongation-associated-with-dronedarone-in-paroxysmal-atrial-fibrillation-and-no-structural-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:56:27Z","timestamp":1766069787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443120-marked-qtc-interval-prolongation-associated-with-dronedarone-in-paroxysmal-atrial-fibrillation-and-no-structural-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.99543","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}